Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Free Cash Flow (2024 - 2025)

Kairos Pharma's Free Cash Flow history spans 2 years, with the latest figure at -$805000.0 for Q2 2025.

  • For Q2 2025, Free Cash Flow fell 379.17% year-over-year to -$805000.0; the TTM value through Dec 2025 reached -$3.3 million, up 16.01%, while the annual FY2025 figure was -$3.4 million, 13.0% up from the prior year.
  • Free Cash Flow reached -$805000.0 in Q2 2025 per KAPA's latest filing, down from -$714000.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $36000.0 in Q1 2024 to a low of -$2.0 million in Q3 2024.